Daily pill may help treat blood cancer patients.Byline: ANI Melbourne, July 26 (ANI): Blood cancer, which has traditionally given sufferers a survival time of just a few years, may soon be curable cur·a·ble adj. Capable of being cured or healed. with the aid of a daily pill. Cancer specialists meeting in Melbourne this weekend are likely to discuss how in future doctors should treat myeloma myeloma /my·elo·ma/ (mi?e-lo´mah) a tumor composed of cells of the type normally found in the bone marrow. giant cell myeloma see under tumor (1). , an incurable blood cancer which effects thousands of people. This form of cancer develops in the bone marrow, inhibits the production of normal blood cells blood cells, n.pl the formed elements of the blood, including red cells (erythrocytes), white cells (leukocytes), and platelets (thrombocytes). blood cells See erythrocyte and leukocyte. Platelets are classed separately. , and causes symptoms such as anaemia anaemia see anemia. , fatigue and infections. "We are seeing a major advance in the treatment of multiple myeloma," news.com.au quoted Royal Melbourne Hospital The Royal Melbourne Hospital (RMH) in Parkville is one of Australia’s leading public hospitals. It is a major teaching hospital for tertiary health care with a reputation in clinical research. oncologist Professor Jeffrey Szer as saying in a statement. "In the past five years for instance, myeloma patient survival, which has traditionally been three to four years, has been significantly extended with the availability of innovative new medicines," Szer added. Thos present at the meeting are likely to hear that a medicine called Revlimid may possibly be used as an oral treatment for the condition. "We are seeing a significant improvement in quality of life and cancer survival rates," Szer said. "There are a number of new treatment strategies that clinicians are adopting to enable them to achieve these outcomes. "Revlimid is an example of an innovative new medicine that has a unique mechanism of action to kill cancer cells and prolong the patient's life. Compelling Revlimid clinical trail data is being discussed at (the) medical symposium this weekend with local and international experts, coinciding with the Leukaemia Foundation's public lecture," Szer added. (ANI) Copyright 2009 Asian News International The Asian News International (ANI) agency provides multimedia news to China and 50 bureaus in India. It covers virtually all of South Asia since its foundation and presently claims, on its official website, to be the leading South Asia-wide news agency. (ANI) - All Rights Reserved. Provided by Syndigate.info an Albawaba.com company |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion